Enjuvia (synthetic Conjugated Estrogens recalls
The FDA has published 3 recalls involving Enjuvia (synthetic Conjugated Estrogens since 2012. The latest was reported on 19 Dec 2012. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2012
Last 12 months0reported
Class I00% of total
Ongoing0latest 19 Dec 2012
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 3 100%
Why enjuvia (synthetic conjugated estrogens is recalled
Companies
By year
All enjuvia (synthetic conjugated estrogens recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Enjuvia (synthetic conjugated estrogens, B) tablets recalled | Physicians Total Care | Potency & Assay | VA |
| Drug | CLASS III | Enjuvia (synthetic conjugated estrogens, B) tablets recalled | Physicians Total Care | Potency & Assay | VA |
| Drug | CLASS III | Enjuvia (synthetic conjugated estrogens, B) tablets recalled | Physicians Total Care | Potency & Assay | VA |
Should you stop taking Enjuvia (synthetic Conjugated Estrogens?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.